Subscribe to our newsletter.
Biosynex France is a leading player in the field of medical diagnostics, renowned for its commitment to innovation and quality. With a history spanning over 15 years, the company has earned a reputation for excellence in producing rapid diagnostic tests.
Biosynex specializes in developing and manufacturing a wide range of in-vitro diagnostic tests, including tests for pregnancy, infectious diseases, cardiovascular markers, and more. Their cutting-edge technologies empower healthcare professionals and individuals to obtain quick, accurate results, improving patient care and management.
Headquartered in Strasbourg, France, Biosynex has expanded its presence worldwide, reaching healthcare providers and patients in over 100 countries. Their global network ensures accessibility to reliable diagnostic tools across diverse healthcare settings.
Commitment to Quality:
Biosynex prioritizes quality and safety in all aspects of its operations. The company adheres to stringent international standards and regulations, ensuring that its products meet the highest standards of accuracy and reliability.
Rapid Response to Challenges:
Biosynex gained prominence during the COVID-19 pandemic for its rapid development and distribution of COVID-19 diagnostic tests. Their agility and dedication played a pivotal role in the global response to the crisis.
As the healthcare landscape continues to evolve, Biosynex remains dedicated to innovation. The company actively invests in research and development to create novel diagnostic solutions that address emerging healthcare challenges.